THE ROLE OF INTESTINAL MICROBIOTA IN THE PATHOGENESIS OF SEPSIS PROGRESSION

Author:

Yakubtsevich R. E.ORCID, ,Lemesh A. V.,

Abstract

Background. Sepsis is a global public health problem and is associated with high mortality rates in all countries. According to recent views, sepsis is defned as life-threatening organ dysfunction caused by an unregulated response of the host to infection. Objective. To analyze the results of scientifc studies confrming the key role of intestinal dysbiosis in the pathophysiology of sepsis. Material and methods. A qualitative analysis of 34 Russian-language and English-language sources concerning the role of the intestinal microbiota in the onset of sepsis was carried out. Results. It has been established that intestinal microbiota plays an important role in the etiology, pathogenesis and treatment of sepsis and its disbalance can trigger the development of sepsis of various etiologies, mainly gram-negative. Conclusions. The analysis of the literature indicates that bacterial translocation can be natural provided that the immune system functions properly. Intestinal microbiota plays one of the leading roles in the development of sepsis. The use of probiotics and transplantation of intestinal microbiota contribute greatly to the treatment and prevention of sepsis in ICU patients.

Publisher

Grodno State Medical University

Subject

Pharmacology (medical)

Reference34 articles.

1. 1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-810. https://doi.org/10.1001/jama.2016.0287

2. 2. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC, Reinhart K; International Forum of Acute Care Trialists. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am. J. Respir Crit. Care Med. 2016;193(3):259-722. https://doi.org/10.1164/rccm.201504-0781OC

3. 3. Kübler A, Adamik B, Ciszewicz-Adamiczka B, Ostrowska E. Severe sepsis in intensive care units in Poland-apoint prevalence study in 2012 and 2013. Anaesthesiol. Intensive Ther. 2015;47(4):315-319. https://doi.org/10.5603/AIT.2015.0047

4. 4. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211. https://doi.org/10.1016/S0140-6736(19)32989-7

5. 5. Zhu LL, Zhou Q. Optimal infusion rate in antimicrobial therapy explosion of evidence in the last five years. Infect. Drug Resist. 2018;11:1105-1117. https://doi.org/10.2147/IDR.S167616

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3